To further verify ERK pathway involvement in the regulation of cancer stemness, we analysed the stem surface markers of CD133 (Figures 5A,D), CD44 (Figures 5B,E), and CD24 (Figures 5C,F). The gene discussed is PROM1; the disease is cancer.